Navigation Links
Surgical patients' mortality rates drop at ACS NSQIP hospitals in California
Date:7/15/2013

SAN DIEGO (July 15, 2013) A new study evaluating surgical outcomes at California hospitals enrolled in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) found surgical patients at ACS NSQIP hospitals had significantly reduced mortality rates compared with non-ACS NSQIP hospitals. These findings were presented Sunday, July 14, 2013 at the ACS NSQIP National Conference, taking place July 13-16 in San Diego, Calif.

Researchers analyzed data from 1,184,895 patients at 227 hospitals from 1995 to 2009 to identify whether surgical outcomes improved over time in ACS NSQIP hospitals compared with non-ACS NSQIP hospitals. Outcome measures included in-hospital mortality, 30-day mortality, 30-day readmissions and one-year mortality rates on seven complex surgical procedures, including: abdominal aortic aneurysm repair, aortic valve replacement, bariatric operations, coronary artery bypass grafting, esophagectomy, pancreatectomy, and percutaneous coronary intervention.

For these procedures the investigators reported that ACS NSQIP hospitals had significantly lower 30-day mortality rates (OR 0.73[0.70-0.76] versus 0.81[0.78-0.83]) and one-year mortality rates (OR 0.84[0.81-0.87] versus 0.90[0.88-0.92]) than non-ACS NSQIP hospitals. The researchers also identified a decrease in 30-day readmission and in-hospital mortality rates, although the difference did not reach statistical significance.

There have been considerable improvements in outcomes of complex surgical procedures in California since 1995; however, during this time period, surgical outcomes and mortality rates at ACS NSQIP hospitals have improved faster than at non-ACS NSQIP hospitals, which may be attributed to increased active participation in ACS NSQIP.

"The magnitude of the decrease in mortality rates at ACS NSQIP hospitals demonstrates a clear distinction between ACS NSQIP hospitals and non-ACS NSQIP hospitals in terms of surgical quality improvement," said David C. Chang, PhD, MPH, MBA, senior author and Director of Outcomes Research in the Department of Surgery at the University of California San Diego (UCSD) School of Medicine. Other investigators on the project include Ralitza P. Parina, MPH, third year medical student at UCSD School of Medicine; Tazo S. Inui, MD, resident in general surgery at UCSD School of Medicine; and Mark A. Talamini, MD, FACS, former Chairman of Surgery at UCSD School of Medicine.

A model for outcomes-based quality improvement, ACS NSQIP collects clinical, risk-adjusted, 30-day outcomes data in a nationally benchmarked database. The program is currently used by approximately 500 hospitals across the U.S. An Annals of Surgery study determined that hospitals participating in ACS NSQIP prevented 250-500 complications, resulting in an average of 13-26 lives saved per hospital, per year*. At $11,000 for an average cost of a complication, the combined potential savings of 4,500 hospitals could add up to $13-26 billion each year, amounting to an estimated total savings of $260 billion over a period of 10 years.


'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
American College of Surgeons
Source:Eurekalert

Related medicine news :

1. da Vinci Surgical Robot News: Rottenstein Law Group LLP Comments on Report of Recall of Some Robot Products
2. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Comments on Opening Statements in First Federal C.R. Bard Surgical Mesh Lawsuit Bellwether Trial
3. Nearly half of sarcoma surgeries done by nonsurgical oncology specialists
4. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by Recent NBC Rock Center Program on Potential Da Vinci Surgical Robot Complications
5. Preventing Simple Surgical Mistakes That Can Have a Lasting Impact
6. Tackling a framework for surgical innovation
7. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Intuitive Surgical’s Decision to Replace Defective da Vinci Surgical Instrument
8. Glidewell International Technology Center Announces a Surgical Hands-on Course on Small-Diameter Dental Implants
9. Black Canyon Surgical Center Goes Paperless with Cyramed ASC EHR System
10. Marshalltown Medical and Surgical Center Retains B. E. Smith to Recruit New CFO
11. Quality improvement educational initiative proves to be a model program for surgical residents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... Freedom, PA (PRWEB) , ... April 22, 2017 ... ... healthcare experience to his role as Vice President of Sales and Business Development ... of key GPO/IDN business partner engagements, business development, and strategic planning for the ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce ... the 2017 London Marathon. Set to take place on April 23rd, the London Marathon has ... Schwartz will run as part of team EMPOWER, raising money for the international charity, Smile ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of ... with the 2017 Ruth Ravich Patient Advocacy Award in recognition of her ... was honored with the award at The Beryl Institute’s annual Patient Experience Conference ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
Breaking Medicine Technology: